We recently published a list of 10 Most Promising Gene Editing Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where bluebird bio, Inc. (NASDAQ:BLUE) stands ...
Researchers completed genomic research on carcasses of the largest animals that have ever lived to understand North Atlantic whale populations. By Darren Incorvaia Darren Incorvaia previously wrote ...
This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...
Seven out of 67 children who were given bluebird bio’s (NASDAQ:BLUE) gene therapy Skysona during clinical trials ended up developing blood cancer, according to a new study. Six of the children who ...
A team of bio-scientists affiliated with a host of institutions across the U.S. has developed a gene editing technique to produce newborn pigs immune to porcine reproductive and respiratory syndrome, ...
In a recent study published in PNAS Nexus, researchers created Drosophila models using multi-omics profiles to elucidate the biological mechanisms and effects of everyday low-intensity blue light ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results